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Abstract
Background: Kawasaki Syndrome (KS) is an uncommon childhood disease with unknown
etiology. It has been suggested that rotavirus infection may play a causative role in the development
of KS.
Methods: To examine potential temporal associations between KS and rotavirus infection,
seasonal patterns of KS- and rotavirus-associated hospitalizations among children in California and
New York during 2000-2005 were compared.
Results: Rotavirus hospital admissions were markedly winter seasonal, with very few summer
hospitalizations. KS hospitalizations occurred year-round but also peaked slightly during winter and
spring.
Conclusion: The strong winter seasonal pattern of rotavirus clearly differed from the year-round
pattern of KS hospitalizations. While the present study cannot completely rule out rotavirus as
having a role in the development of KS, other agents must be involved in the etiology of KS.
Background
In February 2006, a new vaccine against rotavirus,
RotaTeq, was licensed by the US Food and Drug Adminis-
tration, and currently the Advisory Committee on Immu-
nization Practices recommends routine immunization of
all US children against rotavirus, starting at 6 weeks of age
[1]. In June 2007, the FDA revised the package label for
RotaTeq to include information on cases of Kawasaki syn-
drome (KS), due to rare reported cases in pre-licensure
studies [2]. Based on a review of pre-licensure and availa-
ble post-licensure surveillance data, the FDA concluded
that there is not a known cause and effect relationship
between receiving RotaTeq and the occurrence of KS.
KS is an uncommon childhood illness that is character-
ized by high fever and inflammation of the blood vessels
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year in the United States develop KS, about eighty percent
of whom are younger than 5 years of age [3,4]. The cause
of KS is unknown [5]; it has been hypothesized that an
infectious agent is involved in the etiology of KS [6] but
no specific association has been confirmed. In a single
study from Japan, where a higher incidence of KS than in
the United States has been noted, rotavirus particles or
capsomers were identified in 74% of 39 KS cases versus
11% of 18 controls and a rise in serum antibody to rota-
virus was identified in 51% of 75 KS cases versus 8% of 39
controls [7]. While these data raised the possibility of an
association between rotavirus infection and KS, no studies
to confirm these findings have been reported.
Because the etiology of KS remains unknown, and the
possibility of an association between KS and rotavirus
infection has been raised [7], we sought to further exam-
ine the relationship between these diseases. Furthermore,
a better understanding of any potential association
between KS and natural rotavirus infection could help
assess the biologic plausibility of a relationship between
rotavirus vaccination and KS. Therefore, we examined the
seasonal patterns of hospitalizations associated with rota-
virus gastroenteritis and with KS for the US states of Cali-
fornia and New York, to evaluate whether the two diseases
temporally coincided.
Methods
Hospital discharge records for the period from 2000
through 2005 for California and New York residents <5
years of age with KS or with rotavirus listed as a diagnosis
were analyzed from the State Inpatient Database (SID) in
collaboration with the Healthcare Cost and Utilization
Project (HCUP), Agency for Healthcare Research and
Quality [8]. The states partner with the HCUP to produce
the SID. The SID includes of all hospital discharge records
from all community hospitals in the two states. Because
HCUP data is secondary administrative data without clear
patient identifiers, it has been determined that the data is
exempt from ethical approval.
The International Classification of Diseases, 9th revision,
Clinical Modification (ICD-9-CM) [9] code 446.1 was
used to identify KS-associated hospitalizations, and the
code 008.61 was used to identify rotavirus-associated hos-
pitalizations, listed as one of up to 15 or 25 diagnoses on
the discharge record for New York and California, respec-
tively. The average annual hospitalization rates (per
100000 children <5 years of age) were calculated by using
the number of hospitalizations and the corresponding
state census population for 2000 through 2005 [10]. For
comparing the seasonal occurrence of KS and rotavirus,
the hospitalization rates associated with KS and rotavirus
for each state were plotted in comparison to the year and
month of admission. To further assess whether hospitali-
zations due to KS and rotavirus coincide in a temporal
manner, we determined the cumulative monthly propor-
tion of hospitalizations during the 6-year study period for
each of these diseases.
Results
From 2000 through 2005, the annual average rates of hos-
pitalization among children <5 years of age associated
with KS and with rotavirus were 20.7 and 100.7 (per
100,000) in California, respectively, and 23.0 and 112.1
in New York, respectively.
During the study period, the rate of rotavirus-associated
hospitalizations displayed a characteristic winter seasonal
peak with very few cases reported during the summer
months (Figure 1). With the exception of 2005, the rota-
virus hospitalization rate peaked earlier in California than
that in New York, with 1-2 months separating the sea-
sonal peaks in the two states. KS-associated hospitaliza-
tions occurred year round, but the rate also peaked during
the winter months (figure 2); however, the pattern dis-
played variability from year to year. During most years,
the winter peaks of the KS hospitalization rate occurred
earlier in New York than those in California.
To further compare the seasonal pattern of hospitaliza-
tions associated with rotavirus and with KS, we examined
the composite proportion of hospitalizations by month of
admission over the 6-year study period (figure 3). Rotavi-
rus-associated hospitalizations clearly displayed a strong
peak in the winter months, and this peak occurred about
Rotavirus-associated hospitalization rates by month of admis-si n for children <5 years of age in California and New York, 2000-2005Figure 1
Rotavirus-associated hospitalization rates by month 
of admission for children <5 years of age in California 
and New York, 2000-2005.
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contrast, the occurrence of KS-associated admissions dis-
played a smaller peak in the winter and spring months
and the timing of the peaks did not differ substantially
between California and New York.
Discussion
In both California and New York, during 2000-2005, rota-
virus-associated hospitalization rates showed a strong
winter seasonality and were nearly absent during the sum-
mer months, whereas KS-associated hospitalization rates
occurred year round with smaller peaks during the winter
months. Furthermore, the well recognized 1-2 month
delay in winter peaks of rotavirus hospitalizations in the
Northeast United States compared to winter peak the
West United States [11] was not observed for KS-associ-
ated hospitalizations. Together, this does not support a
strong temporal relationship between these diseases, and
implies that other factors are involved in the etiology of
KS. While the etiology of KS is still not understood,
genetic factors, as well as other infectious agents may have
a causative role.
It should be noted that although hospital discharge data
are very useful in understanding disease occurrence, limi-
tations in this methodology exist, for instance, not all
rotavirus infections result in hospitalization. In addition,
studies of this nature do not allow for assessment of indi-
vidual-level associations between etiologic agents. Further
discussions of limitations regarding this data source for KS
and rotavirus, have been described elsewhere [3,4,12].
Finally, discharge data for this study was from all commu-
nity hospitals in CA and NY. Community hospitals repre-
sent approximately 85% of all U.S. hospitals, including
public and private, academic and specialty hospitals. In
California, 98% of all community hospitals are included
in the HCUP data base, and in New York, 100% of all
community hospitals are included. While we believe this
to be representative of discharge for all types of hospitals,
we do not have comparison data which would allow us to
make a definitive assessment.
Conclusion
The occurrence of KS year-round indicates that etiologies
other than rotavirus are involved in the occurrence of KS.
Carefully designed prospective studies with microbiologic
evaluation of clinical specimens from KS cases and an
appropriate comparison group with similar age, sex, and
genetic background are necessary to fully evaluate any
possible causal relationship between KS and infection
with rotavirus.
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Kawasaki syndrome (KS)-associated hospitalization rates by month of admission for children <5 years of age in C lifornia and New York, 2000-2005Figur  2
Kawasaki syndrome (KS)-associated hospitalization 
rates by month of admission for children <5 years of 
age in California and New York, 2000-2005.
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Cumulative monthly proportion of overall rotavirus- and overal  KS-ass ciated h spitalizations, for children <5 years f age in C lif rnia and New York, 2000-2005Figure 3
Cumulative monthly proportion of overall rotavirus- 
and overall KS-associated hospitalizations, for chil-
dren <5 years of age in California and New York, 
2000-2005.
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